Lv2
130 积分 2023-10-27 加入
Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial
7小时前
已完结
Essential Thrombocythemia
11天前
已完结
BOREAS: A Global, Phase III Study of the MDM2 Inhibitor Navtemadlin (KRT-232) in Relapsed/Refractory Myelofibrosis
18天前
已关闭
Immunotherapy based approaches in myelofibrosis
22天前
已完结
Current State of Evidence on Definitions and Management of High-Risk Multiple Myeloma
27天前
已完结
Low dose lenalidomide versus placebo in non-transfusion dependent patients with low risk, del(5q) myelodysplastic syndromes (SintraREV): a randomised, double-blind, phase 3 trial
1个月前
已完结
Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs
1个月前
已完结
Predictive Validity of a QTc Interval Prolongation Risk Score in the Intensive Care Unit
1个月前
已完结
CALR -mutated myeloproliferative neoplasms
2个月前
已完结
皖公网安备34019202002308
